The IBN SINA Pharmaceutical Industry Ltd. reported earnings results for the third quarter and nine months ended March 31, 2022. For the third quarter, the company reported sales was BDT 1,879.43 million compared to BDT 1,791.87 million a year ago. Net income was BDT 86.62 million compared to BDT 86.98 million a year ago.
For the nine months, sales was BDT 6,407.26 million compared to BDT 5,399.37 million a year ago. Net income was BDT 414.5 million compared to BDT 341.33 million a year ago.